Peak6 Investments LLC Novo Cure LTD Call Options Transaction History

Peak6 Investments LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 14, 2024	BUY	$12.42 - $17.29 $93,150 - $129,675	7,500 New	7,500 $117,000
Q1 2023 May 12, 2023	BUY	$56.44 - $118.81 $1.99 Million - $4.19 Million	35,300 New	35,300 $2.12 Million
Q4 2020 Feb 12, 2021	SELL	$112.16 - $174.14 $11 Million - $17.1 Million	-98,200 Reduced 47.26%	109,600 $19 Million
Q3 2020 Nov 13, 2020	BUY	$58.05 - $111.31 $11.5 Million - $22 Million	197,900 Added 1998.99%	207,800 $23.1 Million
Q2 2020 Aug 14, 2020	BUY	$57.2 - $74.41 $280,280 - $364,609	4,900 Added 98.0%	9,900 $587,000
Q1 2020 May 14, 2020	SELL	$57.05 - $95.75 $51,345 - $86,175	-900 Reduced 15.25%	5,000 $337,000
Q3 2019 Nov 08, 2019	BUY	$61.86 - $97.8 $364,974 - $577,020	5,900 New	5,900 $441,000
Q4 2018 Feb 13, 2019	SELL	$28.72 - $52.63 $637,584 - $1.17 Million	-22,200 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$32.0 - $52.4 $710,400 - $1.16 Million	22,200 New	22,200 $1.16 Million

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.31B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.